Risk-reducing surgery in FAP: Role for surgeons beyond the incision

Journal of Surgical Oncology

Volumn 101, Issue 7, 2010, Pages 570-576

  Neuman, H B ^a   Robbins, L ^b,c   Duarte, J ^b   Charlson, M E ^b   Weiser, M R ^a   Guillem, J G ^a   Wong, W D ^a   Temple, L K ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

Decision support; Decisional preferences; Familial adenomatous polyposis; Prophylactic surgery; Qualitative; Shared decision making

Indexed keywords

ADENOMATOUS POLYP; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; DECISION MAKING; DOCTOR PATIENT RELATION; EMOTIONALITY; FEMALE; GENETIC COUNSELING; HEALTH CARE PERSONNEL; HUMAN; MALE; MEDICAL PRACTICE; NURSE; PATIENT DECISION MAKING; PRIORITY JOURNAL; RISK REDUCTION; SCHOOL CHILD; SOCIAL SUPPORT; SURGEON;

EID: 77952038806     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21556     Document Type: Article

References (29)

1. Vasen HF, Moslein G, Alonso A, et al.: Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 2008;57:704-713.
2. Olsen KO, Juul S, Bulow S, et al.: Female fecundity before and after operation for familial adenomatous polyposis. Br J Surg 2003;90:227-231. (Pubitemid 36240275)
3. Soravia C, Klein L, Berk T, et al.: Comparison of ileal pouch-anal anastomosis and ileorectal anastomosis in patients with familial adenomatous polyposis. Dis Colon Rectum 1999;42:1028-1033; discussion 1033-1034.
4. van Duijvendijk P, Slors JF, Taat CW, et al.: Functional outcome after colectomy and ileorectal anastomosis compared with proctocolectomy and ileal pouch-anal anastomosis in familial adenomatous polyposis. Ann Surg 1999;230:648-654.
5. Hassan I, Chua HK, Wolff BG, et al.: Quality of life after ileal pouch-anal anastomosis and ileorectal anastomosis in patients with familial adenomatous polyposis. Dis Colon Rectum 2005;48:2032-2037.
6. Aziz O, Athanasiou T, Fazio VW, et al.: Meta-analysis of observational studies of ileorectal versus ileal pouch-anal anastomosis for familial adenomatous polyposis. Br J Surg 2006;93:407-417.
7. Bertario L, Russo A, Sala P, et al.: Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis. Int J Cancer 2001;95:102-107.
8. Vasen HF, van der Luijt RB, Slors JF, et al.: Molecular genetic tests as a guide to surgical management of familial adenomatous polyposis. Lancet 1996;348:433-435.
9. De Cosse JJ, Bulow S, Neale K, et al.: Rectal cancer risk in patients treated for familial adenomatous polyposis. The Leeds Castle Polyposis Group. Br J Surg 1992;79:1372-1375.
10. Church J, Burke C, McGannon E, et al.: Risk of rectal cancer in patients after colectomy and ileorectal anastomosis for familial adenomatous polyposis: A function of available surgical options. Dis Colon Rectum 2003;46:1175-1181.
11. Bulow S, Bulow C, Vasen HF, et al.: Colectomy and ileorectal anastomosis is still an option for selected patients with familial adenomatous polyposis. Dis Colon Rectum 2008;51:1318-1323.
12. Charles C, Gafni A, Whelan T: Decision-making in the physician-patient encounter: Revisiting the shared treatment decision-making model. Soc Sci Med 1999;49:651-661.
13. Neuman HB, Cabral C, Charlson ME, et al.: Is internet information adequate to facilitate surgical decision-making in familial adenomatous polyposis? Dis Colon Rectum 2007;50:2135-2141.
14. Degner LF, Sloan JA, Venkatesh P: The Control Preferences Scale. Can J Nurs Res 1997;29:21-43.
15. Strauss A, Corbin J: Basics of qualitative research. Thousand Oaks, CA: SAGE Publications, Inc., 1998.
16. Onwuegbuzie A, Collins K: A typology of mixed methods sampling designs in social science research. Qual Rep 2007;12:281-316.
17. Nekhlyudov L, Bower M, Herrinton LJ, et al.:Women's decision-making roles regarding contralateral prophylactic mastectomy. J Natl Cancer Inst Monogr 2005:55-60.
18. Brain K, Gravell C, France E, et al.: An exploratory qualitative study of women's perceptions of risk management options for familial ovarian cancer: Implications for informed decision making. Gynecol Oncol 2004;92:905-913.
19. Belchetz LA, Berk T, Bapat BV, et al.: Changing causes of mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 1996;39:384-387.
20. Nugent KP, Spigelman AD, Phillips RK: Life expectancy after colectomy and ileorectal anastomosis for familial adenomatous polyposis. Dis Colon Rectum 1993;36:1059-1062.
21. Groves CJ, Beveridge G, Swain DJ, et al.: Prevalence and morphology of pouch and ileal adenomas in familial adenomatous polyposis. Dis Colon Rectum 2005;48:816-823.
22. Parc YYR, Olschwang SS, Desaint BB, et al.: Familial adenomatous polyposis: Prevalence of adenomas in the ileal pouch after restorative proctocolectomy. Ann Surg 2001; 233.
23. van Duijvendijk P, Vasen HF, Bertario L, et al.: Cumulative risk of developing polyps or malignancy at the ileal pouch-anal anastomosis in patients with familial adenomatous polyposis. J Gastrointest Surg 1999;3:325-330.
24. Whelan T, O'Brien MA, Villasis-Keever M, et al.: Impact of cancer-related decision aids. Evidence Report/Technology Assessment Number 46. (Prepared by McMaster University under Contract No. 290-97-0017). Rockville, MD: Agency for Healthcare Research and Quality, AHRQ Publication No. 02-E004. 2002.
25. O'Connor AM, Stacey D, Entwistle V, et al.: Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2003: CD001431.
26. Neuman HB, Charlson ME, Temple LK: Is there a role for decision aids in cancer-related decisions? Crit Rev Oncol Hematol 2007;62:240-250.
27. van Roosmalen MS, Stalmeier PF, Verhoef LC, et al.: Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers. J Clin Oncol 2004;22:3293-3301.
28. van Roosmalen MS, Stalmeier PF, Verhoef LC, et al.: Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation. Br J Cancer 2004;90:333-342.
29. Tiller K, Meiser B, Gaff C, et al.: A randomized controlled trial of a decision aid for women at increased risk of ovarian cancer. Med Decis Making 2006;26:360-372.